Gummies Recall: Extract Labs Mai Tai 20mg
Announced 2025-10-01 · FDA
Extract Labs is recalling Mai Tai 20mg Gummies due to potential peanut protein cross-contact. The product is sold in unlabeled bulk packaging for private-label use, with no consumer label applied. About 19,750 gummies were distributed in the United States, Australia, Germany, the United Kingdom, Malaysia, and New Zealand under Lot 25JD042507A with an expiration date of 07/2027.
| Brand | Extract Labs, Inc. |
|---|---|
| Product | Mai Tai 20mg Gummies Brand Name: None - unlabeled bulk (private-label consignee) Generic Name: Dietary Supplement Strength: 20mg CBD and 20mg D9 THC per gummy Dosage: Not declared at bulk stage (consignee determines serving size) Form: Gummy Administration: Oral Intended use: Dietary supplement for further packaging/labeling by consignee Type of packaging: Shipped in poly gusset bags, inside corrugated brown boxes, no consumer label applied. Net wt. Mai Tai: 24 bags x 5kg and 1 bag x 4kg UPC: N/A (unlabeled bulk) Firm name & address: None (no consumer label) |
| Reason | Potential peanut protein cross-contact. |
| Severity | moderate |
| Units affected | 19810 |
| Distribution | Product distributed throughout the United States and Australia, Germany, United Kingdom, Malaysia, and New/Zealand. |
| Agency | FDA |
| Recall / campaign no. | Lot: 25JD042507A EXP: 07/2027 Printed on bulk bag identifier adhesive |
WHAT YOU SHOULD DO
- Do not consume recalled gummies.
- Discontinue use and dispose of the product or return it according to the recall instructions or the retailer’s guidance.
- If you have peanut allergies or experience adverse reactions, contact a healthcare provider and monitor recalls for updates from the FDA.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.